Summit Trail Advisors, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 23 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Summit Trail Advisors, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$224,700
-13.8%
35,0000.0%0.01%
-27.3%
Q1 2023$260,750
+70.5%
35,0000.0%0.01%
+57.1%
Q4 2022$152,950
-22.4%
35,0000.0%0.01%
-36.4%
Q3 2022$197,000
-2.5%
35,0000.0%0.01%
-8.3%
Q2 2022$202,000
-43.1%
35,0000.0%0.01%
-58.6%
Q1 2022$355,000
+22.4%
35,0000.0%0.03%
+52.6%
Q4 2021$290,000
+2.1%
35,0000.0%0.02%
-9.5%
Q3 2021$284,000
+51.9%
35,0000.0%0.02%
+31.2%
Q2 2021$187,00035,0000.02%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 1,583,878$10,168,49712.88%
Redmond Asset Management, LLC 137,689$883,9630.29%
K.J. Harrison & Partners Inc 34,640$216,8910.04%
WASATCH ADVISORS LP 612,088$3,929,6050.02%
Concord Wealth Partners 15,275$98,0660.02%
Caption Management, LLC 100,000$642,0000.01%
Summit Trail Advisors, LLC 35,000$224,7000.01%
NATIXIS 90,250$579,4050.01%
TD Waterhouse Canada Inc. 12,050$90,3460.00%
SIMPLEX TRADING, LLC 39,521$2530.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders